Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

株式のランク #3237
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
株価
$33.33
最終同期: 2026-10-19
時価総額
$5.50B
変化(1日)
-0.68%
変化(1年)
52.58%
国
IN
取引 Gland Pharma Limited (GLAND)

カテゴリー

Healthcare
Gland Pharma Limited(GLAND)の配当利回りの履歴
Gland Pharma Limited(銘柄コード: GLAND)の配当利回り(TTM)は2024-03-31時点で0.00%です。
過去5年間の平均配当利回り: 0.26%
Gland Pharma Limited(GLAND)の2017から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 0.66% -48.84%
2025 1.29% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
類似企業または競合他社の配当利回り(TTM)